Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2005-003911-63-DE
EUCTR2005-003911-63-DE
Active, not recruiting
Not Applicable

Combined Radiochemotherapy with Erbitux (Cetuximab) plus Temozolomide in the primary therapy of Glioblastoma Multiforme (GBM) - Phase I/II Trial

niversity of Heidelberg, Frau I. Gürkan, Kaufmännische Direktorin0 sites46 target enrollmentOctober 26, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Heidelberg, Frau I. Gürkan, Kaufmännische Direktorin
Enrollment
46
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 26, 2005
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity of Heidelberg, Frau I. Gürkan, Kaufmännische Direktorin

Eligibility Criteria

Inclusion Criteria

  • •Histologically confirmed Glioblastoma Multiforme (GBM)
  • •Karnofsky Performance Score \>\=60
  • •Adequate blood values
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Previous Radiotherapy to the brain
  • •or chemotherapy with temozolomide
  • •Previous therapy with an EGFR\-inhibitor
  • •Previous therapy with antibodies

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic CancerPancreatic Cancer
NCT00225784Dartmouth-Hitchcock Medical Center37
Active, not recruiting
Not Applicable
Cetuximab (Erbitux®), capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer: A phase II Pilot Study
EUCTR2006-001371-38-SIInstitute of Oncology Ljubljana
Active, not recruiting
Not Applicable
Cetuximab and cisplatin in addition to radiotherapy in the treatment of stage IIA-III carcinoma of the uterine cervix - a pilot phase II study.Stage IIA-III carcinoma of the uterine cervix.MedDRA version: 8.1Level: LLTClassification code 10041848Term: Squamous cell carcinoma of the cervix
EUCTR2006-003759-19-SEDepartment of Gynecological Oncology, University Hospital, Örebro
Terminated
Phase 1
Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric CancerGastric Cancer
NCT01611506Dr Anna Dorothea Wagner1
Unknown
Phase 2
Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal CancerRectal Cancer
NCT00689702Institute of Oncology Ljubljana43